Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: an analysis of 53 cases

Overview of attention for article published in European Journal of Clinical Microbiology & Infectious Diseases, September 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 33 X posts from 32 X users, with an upper bound of 77,041 followers.

RT @ABsteward: Dual beta-lactams : 🆕️⚡️Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bactere…

RT @ABsteward: Dual beta-lactams : 🆕️⚡️Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bactere…

RT @ABsteward: Dual beta-lactams : 🆕️⚡️Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bactere…

RT @ABsteward: Dual beta-lactams : 🆕️⚡️Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bactere…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 29 additional X posts.